Oncology Medical Centers

Oncology Medical Centers

Alabama
Birmingham: University of Alabama
Clinical research is being conducted on the use of a ribonuclease protein + doxorubicin vs. doxorubicin, in patients with unresectable malignant mesothelioma cancer.

Contact:
Karen Harper, RN, BSN
University of Alabama at Birmingham Comprehensive Cancer Center
1824 Sixth Avenue South
Birmingham, AL 35294-3300

Telephone: 205-934-5092
Email: Karen.Harper@ccc.uab.edu

California
Los Angeles: Tower Hematology/Oncology
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Dee Volkerts, Study Coordinator
Tower Hematology/Oncology
8635 West Third Street, Suite 665W
Los Angeles, CA 90048

San Diego: Sharp Health Care
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Cathy K. Wood, Manager, Oncology Research Program
Sharp Health Care
10835 Road to the Cure
San Diego, CA 92121

Telephone: 858-450-5990 ext. 221

Colorado
Denver: University of Colorado
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Monica Robischon, Study Coordinator
University of Colorado
4200 East 9th Avenue, B-189
Denver, CO 80262

Telephone: 303-372-9108


Florida
Miami: Oncology Hematology Group of South Florida
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Cathy Maxwell, Study Coordinator
Oncology Hematology Group of South Florida
8940 North Kendall Drive, Suite 300E
Miami, FL 33176

Telephone: 305-594-2141 ext. 286

Illinois
Chicago: University of Chicago Medical Center
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Tamara Guterz, Study Coordinator
University of Chicago Medical Center, Section of Hematology/Oncology
5841 S. Maryland Avenue, MC2115
Chicago, IL 60637-1470

Telephone: 773-834-3137

Kentucky
Louisville: Kentuckiana Cancer Institute
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Roxanne Smalley
Kentuckiana Cancer Institute
100 E. Liberty Street, Suite 502
Louisville, KY 40202

Telephone: 502-561-8200

Massachusetts
Worcester: Umass Memorial Cancer Center
Study of an investigational treatment for malignant mesothelioma patients

Contact:
Carolyn Gustison, RN, OCN, Study Coordinator
Umass Memorial Cancer Center
Division of Hematology/Oncology
55 Lake Avenue North
Worcester, MA 01655-001

Telephone: 508-856-1385
Email: judith.odonnell@banyan.ummed.edu

New Jersey
Somerville: Somerset Medical Center
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Oncology Clinical Research Coordinator
Somerset Medical Center
110 Rehill Avenue
Somerville, NJ 08876

Telephone: 908-685-2481
Email: jcraig@somerset-healthcare.com

New York
New York City: Columbia-Presbyterian Medical Center
Phase II trial of combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for treatment of peritoneal mesothelioma.

Contact:
Mary Hesdorffer, RN, BSN, Clinical Research Nurse
Columbia-Presbyterian Medical Center
161 Fort Washington Avenue
New York, NY 10032

Telephone: 212-305-1252


Pennsylvania
Philadelphia: Presbyterian Medical Center, University of PA Health System
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Pat Drobins, Study Coordinator
Presbyterian Medical Center, U. PA Health System
Medical Arts Building
51 North 39th Street
Philadelphia, PA 19104

Telephone: 215-349-8913

Tennessee
Knoxville: Thompson Cancer Survival Center
Study of an investigational treatment for malignant mesothelioma patients

Contact:
Sue Thompson, RN, Manager, Clinical Trials
Thompson Cancer Survival Center
1915 White Avenue
Knoxville, TN 37916

Telephone: 865-541-1893
Email: sbales@corhlth.com

Texas
Austin: Lone Star Oncology
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Tracy Bell, Study Coordinator
Lone Star Oncology
11044 Research Boulevard, Suite D400
Austin, TX 78759

Telephone: 512-343-2103
Email: drjjjc@aol.com

Houston: S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Mesothelioma

Contact:
Oncology Department
S. R. Burzynski Clinic
9432 Old Katy, Suite 200
Houston, TX 77055

Telephone: 713-335-5697
Email: info@burzynskiclinic.com

Houston: MD Anderson Cancer Center
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Oncology Department
MD Anderson Cancer Center
Department of Thoracic Head & Neck Med Onc, Box 432
1515 Holcombe Boulevard
Houston, TX 77030

Telephone: 713-792-7033 ext. 3141

Virginia
Charlottesville: H.O.P.E.
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Hematology Oncology Department
H.O.P.E.
459 Locust Ave.
Charlottesville, VA 22902

Telephone: 434-982-8410

Newport News: Virginia Oncology Associates
Study of an investigational treatment for malignant mesothelioma patients.

Contact:
Virginia Oncology Associates
895 Middle Ground Boulevard #200
Newport News, VA 23606

Telephone: 757-873-9400